These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 16650478)

  • 21. [In vitro antimicrobial activity of defensins from rabbit neutrophils against Pseudomonas aeruginosa and its multiple-drug-resistance strains].
    Zhao WY; Dong BR; Zhou Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):83-5. PubMed ID: 15702789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.
    Saiman L
    Paediatr Respir Rev; 2007 Sep; 8(3):249-55. PubMed ID: 17868923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of beta-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea.
    Suk SE; Yoo JS; Lee JK; Lee KM; Chung GT; Shin ES; Han SY; Lee SH; Kim J; Lee YS
    J Microbiol Biotechnol; 2007 Oct; 17(10):1733-7. PubMed ID: 18156795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single amino acid substitution in PmrB is associated with polymyxin B resistance in clinical isolate of Pseudomonas aeruginosa.
    Abraham N; Kwon DH
    FEMS Microbiol Lett; 2009 Sep; 298(2):249-54. PubMed ID: 19663916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.
    Kanellakopoulou K; Sarafis P; Galani I; Giamarellou H; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Jul; 32(1):33-9. PubMed ID: 18538547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Geladopoulos T; Chrisofos M; Koutoukas P; Vassiliadis J; Alexandrou I; Tsaganos T; Sabracos L; Karagianni V; Pelekanou E; Tzepi I; Kranidioti H; Koussoulas V; Giamarellou H
    Shock; 2006 Oct; 26(4):410-6. PubMed ID: 16980890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemophagocytic syndrome: a rare but specific complication of lung transplantation.
    Oto T; Snell GI; Goto K; Miyoshi S
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):e58-9. PubMed ID: 20554295
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens-associated corneal ulcers.
    Pinna A; Usai D; Sechi LA; Molicotti P; Zanetti S; Carta A
    Cornea; 2008 Apr; 27(3):320-6. PubMed ID: 18362661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk assessment of Pseudomonas aeruginosa in water.
    Mena KD; Gerba CP
    Rev Environ Contam Toxicol; 2009; 201():71-115. PubMed ID: 19484589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
    Rice LB
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S100-5. PubMed ID: 16894511
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 33. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006).
    Yoo J; Sohn ES; Chung GT; Lee EH; Lee KR; Park YK; Lee YS
    Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VDUP1 exacerbates bacteremic shock in mice infected with Pseudomonas aeruginosa.
    Piao ZH; Kim MS; Jeong M; Yun S; Lee SH; Sun HN; Song HY; Suh HW; Jung H; Yoon SR; Kim TD; Lee YH; Choi I
    Cell Immunol; 2012 Nov; 280(1):1-9. PubMed ID: 23246829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa infection after living-donor liver transplantation in adults.
    Hashimoto M; Sugawara Y; Tamura S; Kaneko J; Matsui Y; Kokudo N; Makuuchi M
    Transpl Infect Dis; 2009 Feb; 11(1):11-9. PubMed ID: 18811632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multidrug resistant clones of Pseudomonas aeruginosa in the Czech Republic].
    Nemec A; Maixnerová M; Musílek M
    Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):168-72. PubMed ID: 19051164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital.
    Raja NS; Singh NN
    J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of carbapenem exposure on the risk for digestive tract carriage of intensive care unit-endemic carbapenem-resistant Pseudomonas aeruginosa strains in critically ill patients.
    Peña C; Guzmán A; Suarez C; Dominguez MA; Tubau F; Pujol M; Gudiol F; Ariza J
    Antimicrob Agents Chemother; 2007 Jun; 51(6):1967-71. PubMed ID: 17420207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.